Starpharma links with Syngenta, Novartis, Astrazenica, Adama, and Chemchina, page-36

Rett - welcome

Starpharma is a company that has many irons in the fire

The fact that this announcement has taken a lot of people by surprise shows how tight knit things are at the company

However, having said this, there was a hint of something going on at the "farm" just a few days ago - referring of course to the European Biotech convention in Munich

Those that have been following the company closely would have topped up their holdings

I would suggest by christmas, and in fact maybe even as early as this week before or at the AGM (Thursday) there will be further market sensitive announcements which could possibly propel the script dare I say towards $1.50

Just when you think it could not get any better Starpharma comes out with this ovarian cancer announcement

The analyst at Bell Potter has not taken this new development into account with her last assessment of script price of $1.15

I dare say Starpharma has got a lot more in it's back pocket than many people realise

So in answer to your question - all the "stars" are aligning - and there could be substantial upside to where the share price finished today (My own opinion - closer to this $1.50 I have talked about above)